Grow Taller 4 Idiots

How to Grow Taller

Get Instant Access

1. Wilson C, Dempsey L. Trans-sphenoidal microsurgical removal of 250 pituitary adenomas. J Neurosurg 1978;48:13-22.

2. Schlechte J, Sherman B, Halmi N, et al. Prolactin-secreting pituitary tumors in amenorrheic women: a comprehensive study. Endocr Rev 1980;1:295-308.

3. Thorner MO, Schran HF, Evans WS, Rogol AD, Morris JL, MacLeod RM. A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinaemic women: a study of serum prolactin and bromocriptine levels after a cure and chronic administration of bromocriptine. J Clin Endocrinol Metab 1980;50:1026-1033.

4. Laws ER Jr, Ebersold MJ, Piepgras DG, et al. The role of surgery in the management of prolactinomas. In: MacLeod RM, Thorner MO, Scapagnini U, eds. Prolactin, Basic and Clinical Correlates. New York: Springer-Verlag; 1985: 849-853..

5. Nabarro JD. Acromegaly. Clin Endocrinol 1987;26:481-512.

6. De Pablo F, Eastman RC, Roth J, Gorden P. Plasma prolactin in acromegaly before and after treatment. J Clin Endocrinol Metab 1981;53:344-352.

7. Melmed S. Acromegaly. NEngl J Med 1990;322:966-977.

8. Barkan AL, Beitins IZ, Kelch RP. Plasma insulin-like growth factor/somatomedin C in ac-romegaly: correlation with the degree of growth hormone secretion. J Clin Endocrinol Metab 1988;67:69-73.

9. Bates AS, van't Hoff W, Jones JM, Clayton RN. An audit of outcome of treatment in acromegaly. Q J Med 1993;86:293-299.

10. Orme SM, McNally RJQ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab 1998;83:2730-2734.

11. Swearingen B, Barker FG, Katznelson L, et al. Long-term mortality after trans-sphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3419-3426.

12. Giustina A, Barkan A, Casanueva FF, et al. Criteria for cure of acromegaly: A consensus statement. J Clin Endocrinol Metab 1999;85:526-529.

13. Kaltsas GA, Isidori AM, Florakis D, et al. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab 2001;86:1645-1652.

14. Fahlbusch R, Honneger J, Buchfelder M. Surgical management of acromegaly. Endocrinol Metab Clin North Am. Ed (Melmed S, ed.) 1992;21:669-692.

15. Eastman RC, Gorden P, Roth J. Conventional supervoltage irradiation is an effective treatment for acromegaly. J Clin Endocrinol Metab 1979;48:931-940.

16. Jenkins PJ, Akker S, Chew SL, Besser GM, Monson JP, Grossman AB. Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration. Clin Endocrinol 2000;53:719-724.

17. Trainer PJ, Drake WM, Katznelson L, et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 2000;342:1171-1177.

18. Mampalam TJ, Tyrrell JB, Wilson CB. Trans-sphenoidal microsurgery for Cushing's disease. A report of 216 cases. Ann Intern Med 1998;109:487-493.

19. Lindholm J, Kehlet H. Re-evaluation of the 30-min ACTH test in assessing hypothalamic-pituitary-adrenocortical function. Clin Endocrinol 1987;26:53-59.

20. Hughes NR, Lissett CA, Shalet SM. Growth hormone status following treatment for Cushing's syndrome. Clin Endocrinol 1999;51:61-66.

21. Schteingart DE, Tsao HS, Taylor CI. Sustained remission in Cushing's disease with mitotane and pituitary irradiation. Ann Intern Med 1980;92:613-618.

22. Nelson DH, Meakin JW, Thorn GW. ACTH-producing pituitary tumors following adrenalectomy for Cushing's syndrome. Ann Intern Med 1960;52:560-569.

23. Klibanski A, Deutsch PJ, Jameson JL, et al. Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies. J Clin Endocrinol Metab 1987;64:536-542.

24. Katznelson L, Alexander JM, Klibanski A. Clinically nonfunctioning pituitary adenomas. J ClinEndocrinol Metab 1993;76:1089-1094.

25. Snyder PJ. Gonadotroph cell adenomas of the pituitary. Endocr Rev 1985;6:552-563.

26. Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV. Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 1986;64:713-719.

27. Harris RI, Schatz NJ, Gennarelli T, Savino PJ, Cobbs WH, Snyder PJ. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after trans-sphenoidal surgery. J Clin Endocrinol Metab 1983;6:1288-1293.

28. Mindermann T, Wilson CB. Thyrotropin-producing pituitary adenomas. J Neurosurg 1993;79:521-527.

29. Smallridge RC. Thyrotropin-secreting pituitary tumors. Endocrinol Metab Clin North Am 1987;16:765-792.

30. McCutcheon IE, Weintraub BD, Oldfield EH. Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg 1990;73:674-683.

31. Selman WR, Laws ER, Scheithauer BW, Carpenter SM. The occurrence of dural invasion in pituitary adenomas. J Neurosurg 1986;64:402-407.

32. Doniach I. Pituitary carcinoma. Clin Endocrinol 1992;37:194-195.

33. Kaltsas GA, Grossman AB. Malignant pituitary tumors. Pituitary 1998;1:69-81.

34. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998;89:547-551.

35. Sklar CA. Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 1994;21(suppl 1):18-20.

36. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 1999;90:237-250.

37. Scott RM, Hetelekidis S, Barnes PD, Goumnerova L, Tarbell NJ. Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma- a 20-year experience. Pediatr Neurosurg 1994;21(suppl 1):75-81.

38. Sklar CA. Craniopharyngioma: endocrine sequelae of treatment. Pediatr Neurosurg 1994;21(suppl 1):120-123.

39. Wass JAH, Plowman PN, Jones AE, Besser GM. The treatment of acromegaly by external pituitary irradiation and drugs. In: International Symposium: Challenges in Hypersecretion. Human Growth Hormone. New York: Raven Press; 1985:199-206.

40. Feek CM, McLelland J, Seth J, et al. How effective is external pituitary irradiation for growth hormone-secreting pituitary tumors? Clin Endocrinol 1984;20:401-408.

41. Laws ER, Thapar K. Surgical management of pituitary adenomas. In: Pituitary Tumors. Baillieres Clinical Endocrinology and Metabolism. 1985:391-406.

42. Turner HE, Stratton IM, Byrne JV, Adams CBT, Wass JAH. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation. A follow-up study. Clin Endocrinol 1999;51:281-284.

43. Carroll PV, Christ ER, Bengtsson BA, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 1998;83:382-395.

44. Drake WM, Coyte D, Camacho-Hubner C, et al. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 1998;83:379-381.

45. Trainer PJ, Besser GM. The Bart's Endocrine Protocols. Edinburgh: Churchill Livingstone; 1995.

Was this article helpful?

0 0

Post a comment